CalciMedica posts updated corporate presentation; no specific new data disclosed in filing

CalciMedica, Inc.

Company posted an updated corporate presentation on the 'Investors and Media' section of its website.
Presentation titled 'Developing First-in-Class Therapies for Acute Inflammatory Diseases with High Unmet Need' is dated June 2023.
No financial results, pipeline milestones, or other quantifiable updates are provided in the attached exhibit.
Presentation may be used in discussions with analysts and investors; content is furnished, not filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.